Selection of oligonucleotides for whole-genome microarrays with semi-automatic update

por Golfier, G., Lemoine, S., van Miltenberg, A., Bendjoudi, A., Rossier, J., Le Crom, S., Potier, M.-C.
Publicado 2009

Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression...

por Braudeau, J., Dauphinot, L., Duchon, A., Loistron, A., Dodd, R. H., Hérault, Y., Delatour, B., Potier, M. C.
Publicado 2011

Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice

por Braudeau, J, Delatour, B, Duchon, A, Pereira, P Lopes, Dauphinot, L, de Chaumont, F, Olivo-Marin, J-C, Dodd, RH, Hérault, Y, Potier, M-C
Publicado 2011

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease

por Janel, N, Alexopoulos, P, Badel, A, Lamari, F, Camproux, A C, Lagarde, J, Simon, S, Feraudet-Tarisse, C, Lamourette, P, Arbones, M, Paul, J L, Dubois, B, Potier, M C, Sarazin, M, Delabar, J M
Publicado 2017

Plasma DYRK1A as a novel risk factor for Alzheimer's disease

por Janel, N, Sarazin, M, Corlier, F, Corne, H, de Souza, L C, Hamelin, L, Aka, A, Lagarde, J, Blehaut, H, Hindié, V, Rain, J-C, Arbones, M L, Dubois, B, Potier, M C, Bottlaender, M, Delabar, J M
Publicado 2014

Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer's disease patients

por Corlier, F, Rivals, I, Lagarde, J, Hamelin, L, Corne, H, Dauphinot, L, Ando, K, Cossec, J-C, Fontaine, G, Dorothée, G, Malaplate-Armand, C, Olivier, J-L, Dubois, B, Bottlaender, M, Duyckaerts, C, Sarazin, M, Potier, M-C
Publicado 2015